Goldman Sachs Raises Price Target on Humana (HUM) After CEO Meeting

Goldman Sachs raised its price target on Buy-rated Humana (NYSE: HUM) from $101 to $104 following recent meetings with CEO Mike McAllister in California. The firm maintained EPS at $8.45/$8.25/$9.10 versus Street $8.44/$7.98/$8.90.

The firm comments, "Humana sees continued favorable trends across its businesses with MA growth the key but with also a more positive view on commercial pricing as compared with other recent perspectives."

For an analyst ratings summary and ratings history on Humana click here. For more ratings news on Humana click here.

Shares of Humana closed at $89.03 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Humana and HealthStream partner on Indiana home care workforce
• Powell Industries (POWL) PT Lowered to $235 at Cantor Fitzgerald
• Piper Sandler Reiterates Overweight Rating on Estee Lauder (EL), 'F4Q26 Preview'